NCT00866996View on ClinicalTrials.gov

Community-based Study Comparing Extended-release Methylphenidate and Atomoxetine in Children With Attention-deficit Hyperactivity Disorder

PHASE4CompletedINTERVENTIONAL

Enrollment

1,323

Participants

Timeline

Start Date

Not specified

Study Completion Date

December 31, 2003

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG

Methylphenidate extended-release; Atomoxetine

All Listed Sponsors

lead

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

INDUSTRY